Erasca, Inc.

Contributing Author

Recent Articles by Erasca, Inc.

Nov-25	Erasca to Present at the 8th Annual Evercore Healthcare Conference ERAS GlobeNewswire
Nov-12	Erasca Reports Third Quarter 2025 Business Updates and Financial Results ERAS GlobeNewswire
Nov-06	Erasca Announces Issuance of a U.S. Patent Covering Pan-RAS Molecular Glue ERAS-0015 ERAS GlobeNewswire
Nov-04	Erasca to Present at Upcoming Conferences in November ERAS GlobeNewswire
Sep-02	Erasca to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference ERAS GlobeNewswire
Aug-12	Erasca Reports Second Quarter 2025 Business Updates and Financial Results ERAS GlobeNewswire
Jun-02	Erasca Announces IND Clearance for Potential First-in-Class and Best-in-Class Pan-KRAS Inhibitor ERAS-4001 ERAS GlobeNewswire
May-29	Erasca to Present at Upcoming Investor Conferences in June ERAS GlobeNewswire
May-13	Erasca Reports First Quarter 2025 Business Updates and Financial Results ERAS GlobeNewswire
May-13	Erasca Announces Early Clinical Advancement and Prioritization of RAS-Targeting Franchise Coupled with More than 3 Years of Projected Cash Runway ERAS GlobeNewswire
May-07	Erasca to Present at the Bank of America Securities Health Care Conference ERAS GlobeNewswire